Marimed Inc. MRMD
We take great care to ensure that the data presented and summarized in this overview for MARIMED INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MRMD
View allLatest Institutional Activity in MRMD
Top Purchases
Top Sells
About MRMD
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
Insider Transactions at MRMD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2025
|
Timothy Shaw Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,523
-0.26%
|
$0
$0.11 P/Share
|
|
Mar 01
2025
|
Timothy Shaw Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+0.73%
|
-
|
|
Nov 07
2024
|
Jon R Levine President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
44,026
-0.21%
|
$0
$0.15 P/Share
|
|
Nov 07
2024
|
Jon R Levine President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+0.72%
|
-
|
|
Oct 27
2024
|
Jon R Levine President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
40,764
-0.2%
|
$0
$0.16 P/Share
|
|
Oct 27
2024
|
Jon R Levine President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
138,889
+0.67%
|
-
|
|
Oct 27
2024
|
Timothy Shaw Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,612
-0.37%
|
$0
$0.16 P/Share
|
|
Oct 27
2024
|
Timothy Shaw Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
111,111
+1.25%
|
-
|
|
Sep 07
2024
|
Jon R Levine President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,849
-0.03%
|
$0
$0.16 P/Share
|
|
Sep 07
2024
|
Jon R Levine President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,333
+0.11%
|
-
|
|
Sep 07
2024
|
Timothy Shaw Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,360
-0.07%
|
$0
$0.16 P/Share
|
|
Sep 07
2024
|
Timothy Shaw Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,667
+0.25%
|
-
|
|
Sep 01
2024
|
Timothy Shaw Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
38,156
-0.44%
|
$0
$0.19 P/Share
|
|
Sep 01
2024
|
Timothy Shaw Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
130,000
+1.48%
|
-
|
|
Jun 08
2024
|
Edward J Gildea Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+18.17%
|
-
|
|
Jun 08
2024
|
Eva M.D. Selhub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+40.91%
|
-
|
|
Jun 08
2024
|
Kathleen Tucker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+21.43%
|
-
|
|
Jun 08
2024
|
David R Allen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+40.91%
|
-
|
|
Apr 29
2024
|
Timothy Shaw Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
40,205
-0.47%
|
$0
$0.26 P/Share
|
|
Apr 29
2024
|
Jon R Levine President and CEO |
SELL
Open market or private sale
|
Direct |
50,031
-0.25%
|
$0
$0.26 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 1.19M shares |
|---|
| Payment of exercise price or tax liability | 191K shares |
|---|---|
| Open market or private sale | 90.2K shares |